Chinese President Xi Jinping arrived in Hanoi on Monday to pay a state visit to Vietnam.

AdvaMed and nine other healthcare organizations have continued to pressure the White House to exempt medical devices and critical supplies from the Trump administration’s ongoing tariff saga.

At the 7th China International Import Expo (CIIE), themed "New Era, Shared Future", representatives from 152 countries, regions, and organizations gathered for national and corporate exhibitions. On 8 November, Switze..

Original from: PR Newswire Gestalt, a leading innovator in AI-powered digital pathology solutions, announced the completion of a $7.5 million Series A financing. The round was led by Cowles Ventures, TVF ..

Original from: Revvity · Revenue of $665 million; 2% reported growth; 4% organic growth · GAAP EPS of $0.35; Adjusted EPS from continuing operations of $1.01 · Reaffirms full year 2025 org..

Original from: Merck - Total Worldwide Sales Were $15.5 Billion, a Decrease of 2% From First Quarter 2024; Excluding the Impact of Foreign Exchange, Sales Grew 1% · KEYTRUDA Sales Grew 4% to $7.2..

Original from: Roche · Group sales grew by 6% at constant exchange rates (CER; 7% in CHF), driven by high demand for newer medicines and diagnostic solutions. · Pharmaceuticals Division sales ros..

Peutz-Jeghers syndrome is an autosomal dominant disorder characterized by benign gastrointestinal polyps, hyperpigmented skin spots, and an increased risk of certain cancers.

Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced a strategic collaboration with Pfizer, Inc. (NYSE: PFE), to support the development and commercialization of Pfizer’s oncology portfolio using the Guardant Infinity™ smart liquid biopsy platform.

1. Global IVD Market According to IQVIA statistics, the global IVD market expanded 6% LC in 2023, continuing to show a rebound from the COVID period. In 2023, the global IVD market size reached USD 81 bi..

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the first quarter ended March 29, 2025.

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the introduction of its innovative Chest Pain Triage algorithm as part of the navifyⓇ Algorithm Suite. This groundbreaking algorithm is designed to more quickly and accurately detect Acute Coronary Syndrome (ACS) in patients presenting with chest pain, one of the most common reasons for Emergency Department (ED) visits. As EDs are typically one of the most crowded hospital units, leading to challenges to swiftly diagnose critical conditions, such as chest pain. This new algorithm was developed in collaboration with Universitätsklinikum Heidelberg.

Original from: Quest Diagnostics · First quarter revenues of $2.65 billion, up 12.1% from 2024 · First quarter reported diluted earnings per share ("EPS") of $1.94, up 12.8% from 2024; and adjust..

Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the quarter ended March 28, 2025.

China's healthcare sector is making steady progress in opening up to foreign investment and expertise, with more than 150 joint-venture and wholly overseas-invested medical institutions now operating nationwide, a senior health official announced Monday.

Autobio On April 17, Autobio released its 2024 annual report. The company's operating revenue was RMB 4.471 billion, a slight increase of 0.62% year-on-year. Net profit attributable to shareholders fell 1.89% to..

Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will invest USD 50 billion into the United States of America in the next five years. These investments further strengthen Roche’s already significant US footprint with 13 manufacturing and 15 R&D sites across the Pharmaceutical and Diagnostics Divisions, and are expected to create more than 12,000 new jobs, including nearly 6,500 construction jobs, as well as 1,000 jobs at new and expanded facilities.

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, and North Mississippi Health Services announced today that Labcorp has completed its acquisition of North Mississippi Health Services’ ambulatory outreach laboratory business and become a referral laboratory for its seven hospitals and clinic laboratories.

The Trump administration's fiscal-year 2026 budget proposal calls for a roughly 40 percent cut in funding for the National Institutes of Health.

Diasorin (FTSE MIB: DIA) today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the second1 of its 3 multiplex molecular panels for blood culture pathogen identification on the LIAISON PLEX® system.